EGM
ADVM

Engineers Gate Manager’s Adverum Biotechnologies ADVM Stock Holding History

Engineers Gate Manager’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,577
Closed -$45K – 1797
2021
Q4 		$45K Buy
+2,577
New +$51.6K ﹤0.01% 1879
2021
Q2 		– Sell
-2,440
Closed -$241K – 1565
2021
Q1 		$241K Sell
2,440
-941
-28% -$113K 0.01% 1476
2020
Q4 		$367K Sell
3,381
-3,850
-53% -$476K 0.02% 1166
2020
Q3 		$745K Buy
+7,231
New +$1.08M 0.04% 779
2019
Q4 		– Sell
-1,670
Closed -$91K – 1591
2019
Q3 		$91K Buy
+1,670
New +$188K ﹤0.01% 1315

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Engineers Gate Manager's ADVM Position: Q1 2022 in Review

Engineers Gate Manager sold out of Adverum Biotechnologies (ADVM) in Q1 2022, closing a stake of 2,577 shares — an estimated $45K sold.

Engineers Gate Manager first reported a position in ADVM in Q3 2019 and held it in 5 quarters. The position peaked at $745K in Q3 2020. 92 funds tracked by Wall St. Rank hold ADVM as of Q1 2022.

  • Engineers Gate Manager reported no remaining Adverum Biotechnologies position as of Q1 2022 after selling out during the quarter.
  • Engineers Gate Manager sold 2,577 Adverum Biotechnologies shares in Q1 2022, an estimated $45K.
  • Engineers Gate Manager first reported a position in Adverum Biotechnologies in Q3 2019 and held it in 5 quarters.
  • Engineers Gate Manager's Adverum Biotechnologies position peaked at $745K in Q3 2020.
  • 92 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q1 2022.

Based on Engineers Gate Manager's 13F filing for Q1 2022, filed 16 May 2022.